KDM5B and melanoma: Roesch et al. have indicated that enrichment of the cells with high KDM5B expression during drug treatment of melanoma cells is dependent on high levels of expression for oxidative phosphorylation enzymes of the electron transport chain, such as ubiquinol cytochrome c reductase, NADH dehydrogenase, cytochrome c oxidase, and ATP synthase [173].